MaxCyte hires healthcare veteran Swirsky for CFO job
MaxCyte (NASDAQ:MXCT) on Monday said Douglas Swirsky has been appointed chief financial officer, effective immediately.
Swirsky, who has over two decades of experience in the healthcare sector, notably served as CEO of Rexahn Pharmaceuticals and GenVec.